Delaware court dismisses Accord claims in Seroquel antitrust litigation

Anna Langlois

07 July 2022

Shutterstock/LMWH

Plaintiffs have failed to allege that AstraZeneca’s purported pay-for-delay agreement with Accord Healthcare harmed competition in the market for psychiatric medication Seroquel XR, a federal court has ruled.

Subscribe to Global Competition Review

Subscribe to unlock unlimited access

Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.

Subscribe now

Already have access? Login below

Anna Langlois

View full biography

Author | News reporter, GCR USA

[email protected]

Tipline

Wall-to-wall coverage: The Tipline for 3 February 2023
Unless you're the Oscar-nominated Michelle Yeoh as Evelyn Quan Wang, you cannot be everywhere at once. Whether you’re tasked with trying to convince the Department of Justice to accept a merger settlement or working on a 37-page dissent for the Federal Trade Commission’s sole Republican, GCR USA has you covered on the latest developments in the wonderful world of antitrust. In today’s Tipline, Latham & Watkins legend Dan Wall heads to a company facing …
Virtual reality check: The Tipline for 2 February 2023
Midnight blues: The Tipline for 1 February 2023

Delaware court dismisses Accord claims in Seroquel antitrust litigation

Subscribe to Global Competition Review

Subscribe to unlock unlimited access

Already have access? Login below

Related Topics

Anna Langlois